ImageneBio Return on Equity (ROE) Growth & History (IMA)

ImageneBio's return on equity was −653.53% for fiscal 2023.

View full ImageneBio company overview

ImageneBio annual return on equity history

ImageneBio annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20232023-12-31−653.53%−614.77 pp
20222022-12-31−38.76%+25.11 pp
20212021-12-31−63.87%

ImageneBio return on equity trends

Between the periods ended 2021-12-31 and 2023-12-31, ImageneBio's return on equity decreased from −63.87% to −653.53%, a change of −589.66 percentage points. The latest reported quarter, Q2 2026, shows −7.67%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review ImageneBio source filings ↗

Community posts

It’s quiet here.

No posts about IMA yet. Start the conversation.

Write the first post